Selma Alin Somilleda-Ventura
Research Subjects
Selma Alin Somilleda-Ventura has a total of 40 co-authors. Here are the top co-authors by number of shared publications:
- Virgilio Lima-Gómez
Hospital Juárez de México
8 shared publications - Dulce Milagros Razo Blanco-Hernández
División de Investigación, Hospital Juárez de México, Mexico City 07760, Mexico
3 shared publications Héctor Javier Pérez-Cano
Centro de Investigación Biomédica, Fundación Hospital Nuestra Señora de la Luz I.A.P, Mexico City, Mexico
3 shared publicationsDulce M. Razo-Blanco-Hernández
Servicio de Oftalmología, Hospital Juárez de México, Ciudad de México, México
2 shared publicationsGeovanni Jassiel Ríos-Nequis
Retina and Vitreous Department, Fundación Hospital Nuestra Señora de la Luz IAP, Mexico City, Mexico
2 shared publications- Guillermo Ceballos
Laboratorio de Investigación Integral Cardiometabólica, Escuela Superior de Medicina, Instituto Politécnico Nacional, Mexico City 11340, Mexico
2 shared publications
Latest Publications
- 1 July 2025
- Published by Elsevier in Archives of Medical Research
- Vol. 56 (7) , 103252
Association Between ACE Gene I/D Polymorphism and Diabetic Retinopathy in Mexican Population
- 1 July 2025
- Published by Elsevier in Archives of Medical Research
- Vol. 56 (7) , 103252
Association Between ACE Gene I/D Polymorphism and Diabetic Retinopathy in Mexican Population
- Open Access
- 21 May 2025
- Published by Springer Nature in Discover Medicine
- Vol. 2 (1) , 1-6
Nrf2 aqueous humor shows a higher concentration when GFAP is low in patients with diabetic cataracts versus those with senile cataracts
- 21 May 2025
- Published by Springer Nature in Discover Medicine
- Vol. 2 (1) , 1-6
Open AccessNrf2 aqueous humor shows a higher concentration when GFAP is low in patients with diabetic cataracts versus those with senile cataracts
- Open Access
- 9 September 2024
- Published by Springer Nature in BMC Ophthalmology
- Vol. 24 (1) , 1-7
TNFα and IL-8 vitreous concentrations variations with two antidiabetic therapies in patients with proliferative diabetic retinopathy: an observational study
Antidiabetic therapies are effective, but could indirectly modify the inflammatory response in the ocular microenvironment; therefore, a study was developed to evaluate the inflammatory cytokine profile in the vitreous humor of diabetic patients with retinopathy under treatment with antidiabetic drugs. Observational, comparative, retrospective, cross-sectional study. Interleukins 1β, 6, 8, 10, and tumor necrosis factor-alpha (TNFα) were evaluated in the vitreous humor obtained from patients with type 2 diabetes mellitus, proliferative diabetic retinopathy, and concomitant retinal detachment or vitreous hemorrhage, and who were already on antidiabetic treatment with insulin or metformin + glibenclamide. The quantification analysis of each cytokine was performed by the cytometric bead array (CBA) technique; medians and interquartile ranges were obtained, and the results were compared between groups using the Mann-Whitney U test, where a p-value < 0.05 was considered significant. Thirty-eight samples; quantification of TNFα concentrations was higher in the group of patients administered insulin, while interleukin-8 was lower; in the metformin + glibenclamide combination therapy group, it occurred inversely. In the stratified analysis, the highest concentrations of interleukin-8 and TNFα occurred in patients with vitreous hemorrhage; however, the only statistical difference existed in patients with retinal detachment, whose TNFα concentration in the combined therapy group was the lowest value found (53.50 (33.03–86.66), p = 0.03). Interleukins 1β, 6, and 10 were not detected. Interleukin-8 and TNFα concentrations are opposite between treatment groups; this change is more accentuated in patients with proliferative diabetic retinopathy and vitreous hemorrhage, where the highest concentrations of both cytokines are found, although only TNFα have statistical difference.
- 9 September 2024
- Published by Springer Nature in BMC Ophthalmology
- Vol. 24 (1) , 1-7
Open AccessTNFα and IL-8 vitreous concentrations variations with two antidiabetic therapies in patients with proliferative diabetic retinopathy: an observational study
Antidiabetic therapies are effective, but could indirectly modify the inflammatory response in the ocular microenvironment; therefore, a study was developed to evaluate the inflammatory cytokine profile in the vitreous humor of diabetic patients with retinopathy under treatment with antidiabetic drugs. Observational, comparative, retrospective, cross-sectional study. Interleukins 1β, 6, 8, 10, and tumor necrosis factor-alpha (TNFα) were evaluated in the vitreous humor obtained from patients with type 2 diabetes mellitus, proliferative diabetic retinopathy, and concomitant retinal detachment or vitreous hemorrhage, and who were already on antidiabetic treatment with insulin or metformin + glibenclamide. The quantification analysis of each cytokine was performed by the cytometric bead array (CBA) technique; medians and interquartile ranges were obtained, and the results were compared between groups using the Mann-Whitney U test, where a p-value < 0.05 was considered significant. Thirty-eight samples; quantification of TNFα concentrations was higher in the group of patients administered insulin, while interleukin-8 was lower; in the metformin + glibenclamide combination therapy group, it occurred inversely. In the stratified analysis, the highest concentrations of interleukin-8 and TNFα occurred in patients with vitreous hemorrhage; however, the only statistical difference existed in patients with retinal detachment, whose TNFα concentration in the combined therapy group was the lowest value found (53.50 (33.03–86.66), p = 0.03). Interleukins 1β, 6, and 10 were not detected. Interleukin-8 and TNFα concentrations are opposite between treatment groups; this change is more accentuated in patients with proliferative diabetic retinopathy and vitreous hemorrhage, where the highest concentrations of both cytokines are found, although only TNFα have statistical difference.
- Open Access
N-(2-Hydroxyphenyl)-2-Propylpentanamide (HO-AAVPA) Induces Apoptosis and Cell Cycle Arrest in Breast Cancer Cells, Decreasing GPER Expression
In this work, we performed anti-proliferative assays for the compound N-(2-hydroxyphenyl)-2-propylpentanamide (HO-AAVPA) on breast cancer (BC) cells (MCF-7, SKBR3, and triple-negative BC (TNBC) MDA-MB-231 cells) to explore its pharmacological mechanism regarding the type of cell death associated with G protein-coupled estrogen receptor (GPER) expression. The results show that HO-AAVPA induces cell apoptosis at 5 h or 48 h in either estrogen-dependent (MCF-7) or -independent BC cells (SKBR3 and MDA-MB-231). At 5 h, the apoptosis rate for MCF-7 cells was 68.4% and that for MDA-MB-231 cells was 56.1%; at 48 h, that for SKBR3 was 61.6%, that for MCF-7 cells was 54.9%, and that for MDA-MB-231 (TNBC) was 43.1%. HO-AAVPA increased the S phase in MCF-7 cells and reduced the G2/M phase in MCF-7 and MDA-MB-231 cells. GPER expression decreased more than VPA in the presence of HO-AAVPA. In conclusion, the effects of HO-AAVPA on cell apoptosis could be modulated by epigenetic effects through a decrease in GPER expression.
Open AccessN-(2-Hydroxyphenyl)-2-Propylpentanamide (HO-AAVPA) Induces Apoptosis and Cell Cycle Arrest in Breast Cancer Cells, Decreasing GPER Expression
In this work, we performed anti-proliferative assays for the compound N-(2-hydroxyphenyl)-2-propylpentanamide (HO-AAVPA) on breast cancer (BC) cells (MCF-7, SKBR3, and triple-negative BC (TNBC) MDA-MB-231 cells) to explore its pharmacological mechanism regarding the type of cell death associated with G protein-coupled estrogen receptor (GPER) expression. The results show that HO-AAVPA induces cell apoptosis at 5 h or 48 h in either estrogen-dependent (MCF-7) or -independent BC cells (SKBR3 and MDA-MB-231). At 5 h, the apoptosis rate for MCF-7 cells was 68.4% and that for MDA-MB-231 cells was 56.1%; at 48 h, that for SKBR3 was 61.6%, that for MCF-7 cells was 54.9%, and that for MDA-MB-231 (TNBC) was 43.1%. HO-AAVPA increased the S phase in MCF-7 cells and reduced the G2/M phase in MCF-7 and MDA-MB-231 cells. GPER expression decreased more than VPA in the presence of HO-AAVPA. In conclusion, the effects of HO-AAVPA on cell apoptosis could be modulated by epigenetic effects through a decrease in GPER expression.
- Open Access
- 25 March 2023
- Published by Springer Nature in Scientific Reports
- Vol. 13 (1) , 1-6
Vision-related quality of life after surgery for vitreoretinal disorders in a Mexican population: an observational study
Visual-related quality of life in retinal diseases has not been explored in the Mexican population, so the study aims to identify it in patients undergoing surgery due to advanced diabetic retinopathy, rhegmatogenous retinal detachment, and other causes of vitrectomy; the Visual Function Quality-25 questionnaire was applied to 76 patients, pre-and postoperative. It was divided into 10 domains and interpreted according to the National Eye Institute scores, where the highest value was the best visual function. Student's t-test for related samples and Wilcoxon’s t-test were used to compare each domain between measurements, and Pearson’s R test to correlate the total score of age and quality of life; a p value < 0.05 was considered significant. Diabetic retinopathy patients showed an improvement 1 and 3 months after surgery in all domains; in rhegmatogenous retinal detachment, there was an improvement observed up to 3 months, while a decrease in ocular pain was observed in other causes of vitrectomy. Differences found in all the quality-of-life scores were not statistical, but clinically significant. The study shows that visual-related quality of life domains improves after vitrectomy; the inclusion of this analysis might be considered relevant within the parameters of surgical success of the most prevalent vitreoretinal diseases.
- 25 March 2023
- Published by Springer Nature in Scientific Reports
- Vol. 13 (1) , 1-6
Open AccessVision-related quality of life after surgery for vitreoretinal disorders in a Mexican population: an observational study
Visual-related quality of life in retinal diseases has not been explored in the Mexican population, so the study aims to identify it in patients undergoing surgery due to advanced diabetic retinopathy, rhegmatogenous retinal detachment, and other causes of vitrectomy; the Visual Function Quality-25 questionnaire was applied to 76 patients, pre-and postoperative. It was divided into 10 domains and interpreted according to the National Eye Institute scores, where the highest value was the best visual function. Student's t-test for related samples and Wilcoxon’s t-test were used to compare each domain between measurements, and Pearson’s R test to correlate the total score of age and quality of life; a p value < 0.05 was considered significant. Diabetic retinopathy patients showed an improvement 1 and 3 months after surgery in all domains; in rhegmatogenous retinal detachment, there was an improvement observed up to 3 months, while a decrease in ocular pain was observed in other causes of vitrectomy. Differences found in all the quality-of-life scores were not statistical, but clinically significant. The study shows that visual-related quality of life domains improves after vitrectomy; the inclusion of this analysis might be considered relevant within the parameters of surgical success of the most prevalent vitreoretinal diseases.
- Open Access
- 14 June 2022
- Published by Springer Nature in Research Square
Vision-related quality of life after surgery for vitreoretinal disorders: an observational study
Background: Visual-related quality of life is not always included as a variable of surgical success. However, some questionnaires such as the Visual Function Quality-25 in the Spanish version have proven their reliability and validity, but the quality of life in patients undergoing surgery has not been explored in the Mexican population; so, this study aims to identify it in patients with the most prevalent vitreoretinal diseases.Methods: The Visual Function Quality-25 questionnaire was applied to 76 patients with advanced diabetic retinopathy, rhegmatogenous retinal detachment, and other causes of vitrectomy, pre-and postoperative. It was divided into 10-domains and interpreted according to the National Eye Institute scores, where the highest value was the best visual function. Student's t-test for related samples and Wilcoxon's t-test were used to compare each domain between measurements, and Pearson´s R test to correlate age and quality of life total score; a p-value <0.05 was considered significant.Results: Diabetic retinopathy patients showed an improvement after surgery in all domains, one and three months after surgery; the higher scores were in those who used air o gas as tamponade. In patients with rhegmatogenous retinal detachment, there was an improvement in almost all the items from the first month, with a higher difference observed up to three months, while a decrease in ocular pain was observed in other causes of vitrectomy. Differences found in all the quality-of-life scores at one versus three months were not statistical, but clinically significant.Conclusions: The study shows that visual-related quality of life domains improve after vitrectomy, predominately in diabetic retinopathy subjects; inclusion of this analysis might be considered relevant within the parameters of surgical success of the most prevalent vitreoretinal diseases.
- 14 June 2022
- Published by Springer Nature in Research Square
Open AccessVision-related quality of life after surgery for vitreoretinal disorders: an observational study
Background: Visual-related quality of life is not always included as a variable of surgical success. However, some questionnaires such as the Visual Function Quality-25 in the Spanish version have proven their reliability and validity, but the quality of life in patients undergoing surgery has not been explored in the Mexican population; so, this study aims to identify it in patients with the most prevalent vitreoretinal diseases.Methods: The Visual Function Quality-25 questionnaire was applied to 76 patients with advanced diabetic retinopathy, rhegmatogenous retinal detachment, and other causes of vitrectomy, pre-and postoperative. It was divided into 10-domains and interpreted according to the National Eye Institute scores, where the highest value was the best visual function. Student's t-test for related samples and Wilcoxon's t-test were used to compare each domain between measurements, and Pearson´s R test to correlate age and quality of life total score; a p-value <0.05 was considered significant.Results: Diabetic retinopathy patients showed an improvement after surgery in all domains, one and three months after surgery; the higher scores were in those who used air o gas as tamponade. In patients with rhegmatogenous retinal detachment, there was an improvement in almost all the items from the first month, with a higher difference observed up to three months, while a decrease in ocular pain was observed in other causes of vitrectomy. Differences found in all the quality-of-life scores at one versus three months were not statistical, but clinically significant.Conclusions: The study shows that visual-related quality of life domains improve after vitrectomy, predominately in diabetic retinopathy subjects; inclusion of this analysis might be considered relevant within the parameters of surgical success of the most prevalent vitreoretinal diseases.
- Open Access
- 1 July 2019
- Published by Elsevier in Journal of Optometry
- Vol. 12 (3) , 180-185
Comparison of macular retinal sensitivity and its contribution to the foveal sensitivity between diabetic and non-diabetic patients with normal visual acuity
- 1 July 2019
- Published by Elsevier in Journal of Optometry
- Vol. 12 (3) , 180-185
Open AccessComparison of macular retinal sensitivity and its contribution to the foveal sensitivity between diabetic and non-diabetic patients with normal visual acuity
- 26 June 2019
- Published by Instituto Mexicano del Seguro Social in Cirugía y Cirujanos
- Vol. 87 (4) , 390-395
Circularity of the foveal avascular zone and its correlation with parafoveal vessel density, in subjects with and without diabetes
To characterize the distribution of the foveal avascular zone circularity and its correlation with parafoveal vessel density, in subjects with and without diabetes. Observational, descriptive, cross-sectional, and prospective study; subjects without diabetes (Group 1), with diabetes without retinopathy (Group 2), or with diabetic retinopathy (Group 3) were included. Means of foveal avascular zone circularity and parafoveal vessel density were compared between groups (Kruskal-Wallis) and their correlation was calculated with Spearman's Rho test. Seventy-seven eyes; central vessel density mean was higher in Group 1 than in Group 2 and higher in Group 2 than in Group 3; inner and complete vessel density means were also higher in Group 2 than in Group 3. The mean of the foveal avascular zone circularity did not differ between groups, and in Group 3 it had a positive correlation with central (0.45), inner (0.56), and complete (0.53) vessel densities. Circularity does not differ between subjects with diabetes, with and without retinopathy, and has only a low correlation with parafoveal vessel density in people with diabetic retinopathy, which does not allow anticipating a reduction of vessel density in this disease.
- 26 June 2019
- Published by Instituto Mexicano del Seguro Social in Cirugía y Cirujanos
- Vol. 87 (4) , 390-395
Circularity of the foveal avascular zone and its correlation with parafoveal vessel density, in subjects with and without diabetes
To characterize the distribution of the foveal avascular zone circularity and its correlation with parafoveal vessel density, in subjects with and without diabetes. Observational, descriptive, cross-sectional, and prospective study; subjects without diabetes (Group 1), with diabetes without retinopathy (Group 2), or with diabetic retinopathy (Group 3) were included. Means of foveal avascular zone circularity and parafoveal vessel density were compared between groups (Kruskal-Wallis) and their correlation was calculated with Spearman's Rho test. Seventy-seven eyes; central vessel density mean was higher in Group 1 than in Group 2 and higher in Group 2 than in Group 3; inner and complete vessel density means were also higher in Group 2 than in Group 3. The mean of the foveal avascular zone circularity did not differ between groups, and in Group 3 it had a positive correlation with central (0.45), inner (0.56), and complete (0.53) vessel densities. Circularity does not differ between subjects with diabetes, with and without retinopathy, and has only a low correlation with parafoveal vessel density in people with diabetic retinopathy, which does not allow anticipating a reduction of vessel density in this disease.
- 26 June 2019
- Published by Instituto Mexicano del Seguro Social in Cirugía y Cirujanos
- Vol. 87 (4) , 373-376
Reducción de la sensibilidad foveal en edema macular diabético con agudeza visual 20/20
To compare foveal sensitivity in eyes with and without diabetic macular edema, with 20/20 visual acuity. Non-experimental, comparative, prospective, cross sectional study in eyes with and without retinopathy and focal macular edema, with 20/20 visual acuity. The sample was divided in 3 groups: (1) non-diabetic subjects, (2) diabetics without retinopathy, and 3) diabetics with non-proliferative retinopathy and clinically significant macular edema. Median foveal sensitivity was compared between groups (Kruskal Wallis test). 86 eyes (28 in group 1, 26 in group 2 and 32 in group (3). Medians shown a statistical difference between groups (p = 0.001). Median foveal sensitivity was significantly lower in group 3 than in group 1 (p = 0.001) and than in group 2 (p = 0.03). Median foveal sensitivity did not differ between groups 1 and 2 (p = 0.10). Foveal sensitivity in diabetic macular edema and visual acuity 20/20 is lower in eyes with center sparing clinically significant macular edema and 20/20 visual acuity. The prognostic value of this dysfunction requires evaluation, in order to learn whether early treatment is required in these eyes.
- 26 June 2019
- Published by Instituto Mexicano del Seguro Social in Cirugía y Cirujanos
- Vol. 87 (4) , 373-376
Reducción de la sensibilidad foveal en edema macular diabético con agudeza visual 20/20
To compare foveal sensitivity in eyes with and without diabetic macular edema, with 20/20 visual acuity. Non-experimental, comparative, prospective, cross sectional study in eyes with and without retinopathy and focal macular edema, with 20/20 visual acuity. The sample was divided in 3 groups: (1) non-diabetic subjects, (2) diabetics without retinopathy, and 3) diabetics with non-proliferative retinopathy and clinically significant macular edema. Median foveal sensitivity was compared between groups (Kruskal Wallis test). 86 eyes (28 in group 1, 26 in group 2 and 32 in group (3). Medians shown a statistical difference between groups (p = 0.001). Median foveal sensitivity was significantly lower in group 3 than in group 1 (p = 0.001) and than in group 2 (p = 0.03). Median foveal sensitivity did not differ between groups 1 and 2 (p = 0.10). Foveal sensitivity in diabetic macular edema and visual acuity 20/20 is lower in eyes with center sparing clinically significant macular edema and 20/20 visual acuity. The prognostic value of this dysfunction requires evaluation, in order to learn whether early treatment is required in these eyes.
- 22 May 2019
- Published by Instituto Mexicano del Seguro Social in Cirugía y Cirujanos
- Vol. 87 (3) , 272-277
Baja recurrencia del edema macular diabético focal, 6 meses después de la fotocoagulación
To identify the proportion of eyes with recurrence of diabetic macular edema, six months after focal photocoagulation. Non-experimental, analytical, cross-sectional and prospective study in patients with diabetic macular edema treated with focal photocoagulation. The proportion and 95% confidence intervals (95% CI) of eyes with recurrence of edema were identified; the distribution of anatomical variables and visual acuity was compared between eyes with and without recurrence, using Mann-Whitney's U. 145 eyes were evaluated, and only 10 (95%CI: 2.8-11) had a recurrence. Center point thickness and center field thickness means were higher in eyes with recurrence than in eyes without it, but the difference of change mean betwwen groups was not statistically significant. The proportion of recurrent diabetic macular edema recurrence six months after successful focal photocoagulation was lower than the one reported for other treatments of diabetic macular edema, and by recent studies that used photocoagulation.
- 22 May 2019
- Published by Instituto Mexicano del Seguro Social in Cirugía y Cirujanos
- Vol. 87 (3) , 272-277
Baja recurrencia del edema macular diabético focal, 6 meses después de la fotocoagulación
To identify the proportion of eyes with recurrence of diabetic macular edema, six months after focal photocoagulation. Non-experimental, analytical, cross-sectional and prospective study in patients with diabetic macular edema treated with focal photocoagulation. The proportion and 95% confidence intervals (95% CI) of eyes with recurrence of edema were identified; the distribution of anatomical variables and visual acuity was compared between eyes with and without recurrence, using Mann-Whitney's U. 145 eyes were evaluated, and only 10 (95%CI: 2.8-11) had a recurrence. Center point thickness and center field thickness means were higher in eyes with recurrence than in eyes without it, but the difference of change mean betwwen groups was not statistically significant. The proportion of recurrent diabetic macular edema recurrence six months after successful focal photocoagulation was lower than the one reported for other treatments of diabetic macular edema, and by recent studies that used photocoagulation.